КФУ. Карточка публикации. Preclinical Research of Mesenchymal Stem Cell-Based Therapy for Ocular Diseases

КАЗАНСКИЙ
ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ

RUS

- EN
- 中文
- ES

PRECLINICAL RESEARCH OF MESENCHYMAL STEM CELL-BASED THERAPY FOR OCULAR DISEASES

Форма представления

Зарубежные монографии

Год публикации

2022

Язык

русский

Авторы, сотрудники КФУ

Аймалетдинов Александр Маазович, автор

Закирова Елена Юрьевна, автор

Маланьева Альбина Геннадьевна, автор

Ризванов Альберт Анатольевич, автор

Другие авторы

Rutland Catrin , автор

Библиографическое описание на языке оригинала

Zakirova E. Handbook of Stem Cell Therapy / E. Zakirova, A. M. Aimaletdinov, A. G. Malanyeva, С. S. Rutland, and A. A. Rizvanov; K. H. Haider (ed.). - Springer Nature Singapore Pte Ltd, 2022.

Аннотация

Mesenchymal stem cells (MSC) are specific cell types that enable tissue renewal within the body and are activated during the regeneration processes in response to injury. These cells are present in all human and animal tissues. In medical and biological research, MSCs are isolated and purified from the donor organism and cultured in vitro before use in the treatment of a variety of diseases and conditions associated with tissue damage and cell loss, including ocular lesions. This approach is called cell-based therapy or regenerative medicine. Despite the many existing therapeutic strategies in the area of cell therapy in relation to curing ocular diseases in recent years, advances and new regenerative therapy methods have also been developed and consolidated, giving us a new perspective.

Ключевые слова

Stem cells, ocular disease, therapy.

URL

https://link.springer.com/referencework/10.1007/978-981-16-6016-0?page=1#toc

Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на эту карточку

https://repository.kpfu.ru/?p_id=265061

Файлы ресурса

Название файла	Размер (Мб)	Формат
F_Zakirova2022_ReferenceWorkEntry_PreclinicalResearchOfMesenchym.pdf	0,33	pdf	посмотреть / скачать

Полная запись метаданных

Поле DC	Значение	Язык
dc.contributor.author	Аймалетдинов Александр Маазович	ru_RU
dc.contributor.author	Закирова Елена Юрьевна	ru_RU
dc.contributor.author	Маланьева Альбина Геннадьевна	ru_RU
dc.contributor.author	Ризванов Альберт Анатольевич	ru_RU
dc.contributor.author	Rutland Catrin	ru_RU
dc.date.accessioned	2022-01-01T00:00:00Z	ru_RU
dc.date.available	2022-01-01T00:00:00Z	ru_RU
dc.date.issued	2022	ru_RU
dc.identifier.citation	Zakirova E. Handbook of Stem Cell Therapy / E. Zakirova, A. M. Aimaletdinov, A. G. Malanyeva, С. S. Rutland, and A. A. Rizvanov; K. H. Haider (ed.). - Springer Nature Singapore Pte Ltd, 2022.	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/?p_id=265061	ru_RU
dc.description.abstract	Mesenchymal stem cells (MSC) are specific cell types that enable tissue renewal within the body and are activated during the regeneration processes in response to injury. These cells are present in all human and animal tissues. In medical and biological research, MSCs are isolated and purified from the donor organism and cultured in vitro before use in the treatment of a variety of diseases and conditions associated with tissue damage and cell loss, including ocular lesions. This approach is called cell-based therapy or regenerative medicine. Despite the many existing therapeutic strategies in the area of cell therapy in relation to curing ocular diseases in recent years, advances and new regenerative therapy methods have also been developed and consolidated, giving us a new perspective.	ru_RU
dc.language.iso	ru	ru_RU
dc.subject	Stem cells	ru_RU
dc.subject	ocular disease	ru_RU
dc.subject	therapy.	ru_RU
dc.title	Preclinical Research of Mesenchymal Stem Cell-Based Therapy for Ocular Diseases	ru_RU
dc.type	Зарубежные монографии	ru_RU